Published in Biophys J on June 01, 1981
Membrane conductance of an electroporated cell analyzed by submicrosecond imaging of transmembrane potential. Biophys J (1991) 3.01
High-resolution nonlinear optical imaging of live cells by second harmonic generation. Biophys J (1999) 2.74
Improved fluorescent probes for the measurement of rapid changes in membrane potential. Biophys J (1982) 2.51
Membrane potential induced by external electric field pulses can be followed with a potentiometric dye. Biophys J (1987) 1.98
Coherent scattering in multi-harmonic light microscopy. Biophys J (2001) 1.94
Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys J (1994) 1.93
Nonlinear optical measurement of membrane potential around single molecules at selected cellular sites. Proc Natl Acad Sci U S A (1999) 1.46
Palette of fluorinated voltage-sensitive hemicyanine dyes. Proc Natl Acad Sci U S A (2012) 1.41
Charge-shift probes of membrane potential. Characterization of aminostyrylpyridinium dyes on the squid giant axon. Biophys J (1985) 1.41
Combining voltage and calcium imaging from neuronal dendrites. Cell Mol Neurobiol (2008) 1.36
Membrane electric properties by combined patch clamp and fluorescence ratio imaging in single neurons. Biophys J (1998) 1.35
Sensitivity of second harmonic generation from styryl dyes to transmembrane potential. Biophys J (2004) 1.26
Analysis of the effect of medium and membrane conductance on the amplitude and kinetics of membrane potentials induced by externally applied electric fields. Biophys J (1989) 1.23
Monitoring biophysical properties of lipid membranes by environment-sensitive fluorescent probes. Biophys J (2009) 1.21
Isolation of bright aggregate fluctuations in a multipopulation image correlation spectroscopy system using intensity subtraction. Biophys J (2003) 1.17
Amino(oligo)thiophene-based environmentally sensitive biomembrane chromophores. J Org Chem (2008) 0.97
High-precision recording of the action potential in isolated cardiomyocytes using the near-infrared fluorescent dye di-4-ANBDQBS. Am J Physiol Heart Circ Physiol (2010) 0.96
Confocal imaging of transmembrane voltage by SEER of di-8-ANEPPS. J Gen Physiol (2013) 0.92
Fluorescence emission spectral shift measurements of membrane potential in single cells. Biophys J (2001) 0.92
Imaging membrane potential in dendrites and axons of single neurons. Pflugers Arch (2006) 0.91
Voltage sensitivity of the fluorescent probe RH421 in a model membrane system. Biophys J (1995) 0.88
Distinction between changes in membrane potential and surface charge upon chemotactic stimulation of Escherichia coli. Biophys J (1984) 0.88
Imaging activity of neuronal populations with new long-wavelength voltage-sensitive dyes. Brain Cell Biol (2009) 0.87
Two mechanisms by which fluorescent oxonols indicate membrane potential in human red blood cells. Biophys J (1990) 0.85
The effect of asymmetric surface potentials on the intramembrane electric field measured with voltage-sensitive dyes. Biophys J (2003) 0.85
Porphyrins for probing electrical potential across lipid bilayer membranes by second harmonic generation. Angew Chem Int Ed Engl (2013) 0.85
Simple enrichment and analysis of plasma lysophosphatidic acids. Analyst (2013) 0.82
Enhanced aqueous solubility of long wavelength voltage-sensitive dyes by covalent attachment of polyethylene glycol. Org Biomol Chem (2007) 0.80
How DASPMI reveals mitochondrial membrane potential: fluorescence decay kinetics and steady-state anisotropy in living cells. Biophys J (2008) 0.78
Probing the orientational distribution of dyes in membranes through multiphoton microscopy. Biophys J (2012) 0.77
Comparison of two voltage-sensitive dyes and their suitability for long-term imaging of neuronal activity. PLoS One (2013) 0.76
Highly efficient microscale purification of glycerophospholipids by microfluidic cell lysis and lipid extraction for lipidomics profiling. Anal Chem (2011) 0.75
Spectral characteristics of voltage-sensitive indocyanine green fluorescence in the heart. Sci Rep (2017) 0.75
Optical measurement of membrane potential. Rev Physiol Biochem Pharmacol (1978) 4.22
Changes in axon fluorescence during activity: molecular probes of membrane potential. J Membr Biol (1974) 3.80
Changes in absorption, fluorescence, dichroism, and Birefringence in stained giant axons: : optical measurement of membrane potential. J Membr Biol (1977) 3.49
Charge shift optical probes of membrane potential. Theory. Biochemistry (1978) 2.19
Mechanisms of rapid optical changes of potential sensitive dyes. Ann N Y Acad Sci (1977) 2.15
Evidence for a charge-shift electrochromic mechanism in a probe of membrane potential. Nature (1979) 1.90
Fluorescence spectroscopy of an oriented model membrane. Proc Natl Acad Sci U S A (1971) 1.82
Species-specific effects on the optical signals of voltage-sensitive dyes. J Membr Biol (1979) 1.76
Mechanism of the membrane potential sensitivity of the fluorescent membrane probe merocyanine 540. Biochemistry (1978) 1.52
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 32.92
Spectra, membrane binding, and potentiometric responses of new charge shift probes. Biochemistry (1985) 3.42
The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev (1981) 2.91
Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys J (1988) 2.90
Optical imaging of cell membrane potential changes induced by applied electric fields. Biophys J (1986) 2.82
Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc Natl Acad Sci U S A (1985) 2.80
High-resolution nonlinear optical imaging of live cells by second harmonic generation. Biophys J (1999) 2.74
Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol (1986) 2.66
Simultaneous imaging of cell and mitochondrial membrane potentials. Biophys J (1989) 2.46
Virtual Cell modelling and simulation software environment. IET Syst Biol (2008) 2.43
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2008) 2.40
Charge shift optical probes of membrane potential. Theory. Biochemistry (1978) 2.19
A general computational framework for modeling cellular structure and function. Biophys J (1997) 2.19
Design and characterization of electrochromic membrane probes. J Biochem Biophys Methods (1982) 2.01
Membrane potential induced by external electric field pulses can be followed with a potentiometric dye. Biophys J (1987) 1.98
Second-harmonic imaging microscopy of living cells. J Biomed Opt (2001) 1.97
Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys J (1994) 1.93
Novel naphthylstyryl-pyridium potentiometric dyes offer advantages for neural network analysis. J Neurosci Methods (2004) 1.91
Evidence for a charge-shift electrochromic mechanism in a probe of membrane potential. Nature (1979) 1.90
Dual-wavelength ratiometric fluorescence measurements of membrane potential. Biochemistry (1989) 1.84
Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther (1980) 1.79
Probing membrane potential with nonlinear optics. Biophys J (1993) 1.70
Nationwide data confirms absence of 'July phenomenon' in obstetrics: it's safe to deliver in July. J Perinatol (2007) 1.66
Electric field-directed fibroblast locomotion involves cell surface molecular reorganization and is calcium independent. J Cell Biol (1994) 1.55
Molecular basis for the pathological actions of Clostridium perfringens iota toxin. Infect Immun (1987) 1.47
The virtual cell. Pac Symp Biocomput (1999) 1.47
Localized membrane depolarizations and localized calcium influx during electric field-guided neurite growth. Neuron (1992) 1.46
Nonlinear optical measurement of membrane potential around single molecules at selected cellular sites. Proc Natl Acad Sci U S A (1999) 1.46
Topology of the mitochondrial inner membrane: dynamics and bioenergetic implications. IUBMB Life (2002) 1.46
Cost issues surrounding the use of computerized telemedicine for obstetric ultrasonography. Ultrasound Obstet Gynecol (1998) 1.42
Charge-shift probes of membrane potential. Characterization of aminostyrylpyridinium dyes on the squid giant axon. Biophys J (1985) 1.41
Intracellular fluorescent probe concentrations by confocal microscopy. Biophys J (1998) 1.39
Membrane electric properties by combined patch clamp and fluorescence ratio imaging in single neurons. Biophys J (1998) 1.35
Cellular and molecular actions of binary toxins possessing ADP-ribosyltransferase activity. Toxicon (1991) 1.34
The role of calcium in neurohumoral and neurohormonal extrusion processes. J Pharm Pharmacol (1968) 1.29
Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin. J Pharmacol Exp Ther (1984) 1.29
Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J Biol Chem (1998) 1.29
Synaptic vesicle movements monitored by fluorescence recovery after photobleaching in nerve terminals stained with FM1-43. J Neurosci (1996) 1.28
Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology (2006) 1.27
Determination of time-dependent inositol-1,4,5-trisphosphate concentrations during calcium release in a smooth muscle cell. Biophys J (1999) 1.25
An image-based model of calcium waves in differentiated neuroblastoma cells. Biophys J (2000) 1.25
Analysis of the effect of medium and membrane conductance on the amplitude and kinetics of membrane potentials induced by externally applied electric fields. Biophys J (1989) 1.23
Induction of an immune response by oral administration of recombinant botulinum toxin. Infect Immun (1997) 1.21
Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect Immun (1999) 1.20
Distinct electric potentials in soma and neurite membranes. Neuron (1994) 1.19
A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins. J Pharmacol Exp Ther (1982) 1.15
Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine. Biochem Pharmacol (1978) 1.15
Physiological modeling with virtual cell framework. Methods Enzymol (2000) 1.12
Technical features of a CCD video camera system to record cardiac fluorescence data. Ann Biomed Eng (1997) 1.10
Morphological control of inositol-1,4,5-trisphosphate-dependent signals. J Cell Biol (1999) 1.10
Fluorescent indicators of membrane potential: microspectrofluorometry and imaging. Methods Cell Biol (1989) 1.10
In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches. J Pharmacol Exp Ther (1997) 1.07
Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. J Pharmacol Exp Ther (1983) 1.05
The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids. J Neurochem (1971) 1.00
Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation. J Pharmacol Exp Ther (1975) 0.99
Initiation of sodium spikelets in basal dendrites of neocortical pyramidal neurons. J Membr Biol (2005) 0.98
Fluorometric analysis of transferable membrane pores. Biochemistry (1985) 0.97
Pharmacological studies on the subcellular site of action of botulinum toxin type A. J Pharmacol Exp Ther (1978) 0.95
An adenoviral vector-based mucosal vaccine is effective in protection against botulism. Gene Ther (2009) 0.95
The interaction between aminoquinolines and presynaptically acting neurotoxins. J Pharmacol Exp Ther (1982) 0.94
Isolation and characterization of the Botulinum neurotoxins. Methods Enzymol (1988) 0.94
Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus). J Biol Chem (1986) 0.93
Actions of calcium and magnesium on the rate of onset of botulinum toxin paralysis of the rat diaphragm. Int J Neuropharmacol (1967) 0.93
Cloning and sequence analysis of a cDNA encoding human syntaxin 1A, a polypeptide essential for exocytosis. Gene (1995) 0.92
Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. J Pharmacol Exp Ther (1991) 0.92
Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamine. J Pharmacol Exp Ther (1978) 0.92
Diffusion potential cascade. Convenient detection of transferable membrane pores. Biochemistry (1983) 0.91
Maximal amniotic fluid index as a prognostic factor in pregnancies complicated by polyhydramnios. Ultrasound Obstet Gynecol (2012) 0.90
Wavelength- and time-dependence of potentiometric non-linear optical signals from styryl dyes. J Membr Biol (2005) 0.90
Ganglioside inactivation of botulinum toxin. J Neurochem (1971) 0.90
Isolation, characterization and partial purification of a transferable membrane channel (amoebapore) produced by Entamoeba histolytica. Mol Biochem Parasitol (1989) 0.90
Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission. Neuropharmacology (1971) 0.89
Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells. J Pharmacol Exp Ther (1988) 0.89
A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism. Infect Immun (1986) 0.88
Faster voltage-dependent activation of Na+ channels in growth cones versus somata of neuroblastoma N1E-115 cells. Biophys J (1996) 0.88
The action of botulinal toxin. Rev Infect Dis (1980) 0.88
Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparation. Neuropharmacology (1974) 0.88
Validation of fetal telemedicine as a new obstetric imaging technique. Am J Obstet Gynecol (1997) 0.87
Dye screening and signal-to-noise ratio for retrogradely transported voltage-sensitive dyes. J Neurosci Methods (1996) 0.87
The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin. J Pharmacol Exp Ther (1984) 0.87
Application of Forster resonance energy transfer to interactions between cell or lipid vesicle surfaces. Biochem Biophys Res Commun (1979) 0.87
Cardiorespiratory function is altered by picomole injections of 5'-N-ethylcarboxamidoadenosine into the nucleus tractus solitarius of rats. Brain Res (1990) 0.86
Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships. J Pharmacol Exp Ther (1983) 0.85
STAT module can function as a biphasic amplitude filter. Syst Biol (Stevenage) (2005) 0.84
Electrophysiological manifestations of experimental botulinal intoxication: depression of cortical EEG. Exp Neurol (1967) 0.84
The interaction between divalent cations and botulinum toxin type A in the paralysis of the rat phrenic nerve-hemidiaphragm preparation. Neuropharmacology (1973) 0.83
Tetanus toxin and neuronal membranes: the relationship between binding and toxicity. J Pharmacol Exp Ther (1991) 0.83
Pharmacological experiments on the binding and internalization of the 50,000 dalton carboxyterminus of tetanus toxin at the cholinergic neuromuscular junction. J Pharmacol Exp Ther (1985) 0.82
Validation of first-trimester telemedicine as an obstetric imaging technology: a feasibility study. Obstet Gynecol (1997) 0.82
CaMKII activation and dynamics are independent of the holoenzyme structure: an infinite subunit holoenzyme approximation. Phys Biol (2012) 0.82
Insertion of amphiphilic molecules into membranes is catalyzed by a high molecular weight non-ionic surfactant. Biochim Biophys Acta (1987) 0.81
Failure to inhibit in vitro or in vivo acetycholinesterase with botulinum toxin type A. J Bacteriol (1969) 0.81
Phospholipid vesicle fusion monitored by fluorescence energy transfer. Biochem Biophys Res Commun (1979) 0.80
Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments. Neuroscience (2011) 0.80
Cardiorespiratory effects of inositol hexakisphosphate following microinjections into the nucleus tractus solitarii. Eur J Pharmacol (1989) 0.80
The role of transglutaminase in the mechanism of action of tetanus toxin. J Biol Chem (1994) 0.80
Epithelial cell differentiation in organotypic cultures of fetal rat lung. Am J Anat (1985) 0.80
Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin. J Pharmacol Exp Ther (1984) 0.80
The binding of botulinum toxin to membrane lipids: phospholipids and proteolipid. J Neurochem (1971) 0.79
The role of acetylcholine receptors and acetylcholinesterase activity in the development of denervation supersensitivity. J Pharmacol Exp Ther (1976) 0.79